Pfizer Inc
(PFE)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 09-2005 | 06-2005 | 03-2005 | 12-2004 | 09-2004 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,352,000 | 3,763,000 | 301,000 | 11,361,000 | 8,536,000 |
| Depreciation Amortization | 4,143,000 | 2,776,000 | 1,366,000 | 5,093,000 | 3,782,000 |
| Income taxes - deferred | -1,121,000 | -838,000 | 479,000 | -1,767,000 | -471,000 |
| Accounts receivable | N/A | N/A | N/A | -465,000 | N/A |
| Other Working Capital | -1,527,000 | -369,000 | -237,000 | -600,000 | -2,856,000 |
| Other Operating Activity | 3,149,000 | 1,651,000 | 1,284,000 | 2,718,000 | 1,359,000 |
| Operating Cash Flow | $9,996,000 | $6,983,000 | $3,193,000 | $16,340,000 | $10,350,000 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 6,339,000 | 5,129,000 | -2,360,000 | -5,776,000 | -4,942,000 |
| PPE Investments | -1,493,000 | -997,000 | -465,000 | -2,601,000 | -1,526,000 |
| Net Acquisitions | -1,996,000 | -154,000 | 93,000 | -987,000 | -251,000 |
| Purchase Of Investment | -650,000 | -560,000 | -494,000 | -1,329,000 | -1,132,000 |
| Sale Of Investment | 655,000 | 568,000 | 437,000 | 1,570,000 | 1,432,000 |
| Other Investing Activity | -148,000 | 183,000 | 84,000 | -299,000 | -314,000 |
| Investing Cash Flow | $2,707,000 | $4,169,000 | $-2,705,000 | $-9,422,000 | $-6,733,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 9,000 | 90,000 | 1,591,000 | 2,466,000 | 2,094,000 |
| Debt Issued | 5,000 | 2,000 | 1,000 | 2,586,000 | 2,592,000 |
| Debt Repayment | -1,042,000 | -22,000 | -1,000 | -664,000 | -29,000 |
| Common Stock Issued | 346,000 | 278,000 | 115,000 | 1,012,000 | 909,000 |
| Common Stock Repurchased | -3,415,000 | -3,304,000 | -919,000 | -6,659,000 | -4,787,000 |
| Dividend Paid | -4,177,000 | -2,930,000 | -1,400,000 | -5,082,000 | -3,821,000 |
| Other Financing Activity | -5,274,000 | -5,800,000 | -205,000 | -288,000 | -238,000 |
| Financing Cash Flow | $-13,548,000 | $-11,686,000 | $-818,000 | $-6,629,000 | $-3,280,000 |
| Exchange Rate Effect | -4,000 | 2,000 | -2,000 | -1,000 | 7,000 |
| Beginning Cash Position | 1,808,000 | 1,808,000 | 1,808,000 | 1,520,000 | 1,520,000 |
| End Cash Position | 959,000 | 1,276,000 | 1,476,000 | 1,808,000 | 1,864,000 |
| Net Cash Flow | $-849,000 | $-532,000 | $-332,000 | $288,000 | $344,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 9,996,000 | 6,983,000 | 3,193,000 | 16,340,000 | 10,350,000 |
| Capital Expenditure | -1,493,000 | -997,000 | -465,000 | -2,601,000 | -1,526,000 |
| Free Cash Flow | 8,503,000 | 5,986,000 | 2,728,000 | 13,739,000 | 8,824,000 |